CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

OXGN's Free Cash Flow Growth by Quarter and Year

Mateon Therapeutics Inc's Free Cash Flow results by quarter and year




OXGN Free Cash Flow (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -0.94 -0.63 -3.34
III Quarter September - -0.44 -0.88 -3.70
II Quarter June 0.23 1.52 -0.79 -7.29
I Quarter March 0.03 -0.91 -3.10 -3.55
FY   0.26 -0.77 -5.40 -17.88



OXGN Free Cash Flow second quarter 2020 Y/Y Growth Comment
Mateon Therapeutics Inc reported drop in Free Cash Flow in the second quarter by -85.04% to $ 0.23 millions, from the same quarter in 2019.
The fall in the second quarter Mateon Therapeutics Inc's Free Cash Flow compares unfavorably to the Company's average Free Cash Flow doubling of 622.73%.

According to the results reported in the second quarter, Mateon Therapeutics Inc achieved the best Free Cash Flow growth in Biotechnology & Drugs industry. While Mateon Therapeutics Inc' s Free Cash Flow meltdown of -85.04% ranks overall at the positon no. 109 in the second quarter.




OXGN Free Cash Flow ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June -85.04 % - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mateon Therapeutics Inc's second quarter 2020 Free Cash Flow $ 0.23 millions OXGN's Income Statement
Mateon Therapeutics Inc's second quarter 2019 Free Cash Flow $ 1.52 millions Quarterly OXGN's Income Statement
New: More OXGN's historic Free Cash Flow Growth >>


OXGN Free Cash Flow (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June 658.22 % - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #19
Overall #109

Free Cash Flow Y/Y Growth Statistics
High Average Low
622.73 % 622.73 % 622.73 %
(Jun 30 2020)  
Free Cash Flow second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #19
Overall #109
Free Cash Flow Y/Y Growth Statistics
High Average Low
622.73 % 622.73 % 622.73 %
(Jun 30 2020)  

Free Cash Flow by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mateon Therapeutics Inc's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
622.73 % 622.73 % 622.73 %
(Jun 30 2020)  


OXGN's II. Quarter Q/Q Free Cash Flow Comment
Mateon Therapeutics Inc achieved in the II. Quarter 2020 above company average sequential Free Cash Flow doubling of 658.22%, to $ 0.23 millions, from $0.03 millions in the first quarter.
Mateon Therapeutics Inc is impressively improving, with claiming above normal growth, but also improving pace, Luca  G. Wright, a business observer allocated in Dublin added.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Mateon Therapeutics Inc's Free Cash Flow growth quarter on quarter, overall rank is 109.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #19
Overall #109
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #19
Overall #109
Free Cash Flow Q/Q Growth Statistics
High Average Low
622.73 % 622.73 % 622.73 %
(Jun 30 2020)  


OXGN's II. Quarter Q/Q Free Cash Flow Comment
Mateon Therapeutics Inc achieved in the II. Quarter 2020 above company average sequential Free Cash Flow doubling of 658.22%, to $ 0.23 millions, from $0.03 millions in the first quarter.
OXGN is impressively improving, with claiming above regular increase, and also accelerating pace, Luca  G. Wright, a business observer allocated in Dublin added.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Mateon Therapeutics Inc's Free Cash Flow growth quarter on quarter, overall rank is 109.


Mateon Therapeutics Inc's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
Cumulative Free Cash Flow 12 Months Ending $ -1.13 $ 0.17 $ -0.77 $ -0.45 $ -0.89
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Mateon Therapeutics Inc' has realized cumulative trailing twelve months free cash outflow of $ -1 millions in the Jun 30 2020 period.
The business is worsening as the cumulative free cash outflow is inflating from $ 0.17 millions in TTM ending quarter Mar 31 2020 and $ 0.03 millions from the TTM period ending Jun 30 2019.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Mateon Therapeutics Inc' has realized cumulative trailing twelve months free cash outflow of $ -1 millions in the Jun 30 2020 period.
The situation is detiriorating as the cumulative free cash outflow is getting bigger from $ 0.17 millions in the twelve months ending a quarter before and $ 0.03 millions for the twelve months ending in the quarter Jun 30 2019.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Biotechnology & Drugs Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
OXGN's Free Cash Flow Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for OXGN's Competitors
Free Cash Flow Growth for Mateon Therapeutics Inc's Suppliers
Free Cash Flow Growth for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's Dividend Payout Ratio
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons



Companies with similar Free Cash Flow doubling for the quarter ending Jun 30 2020 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Jun 30 2020
Myriad Genetics Inc -4.76 %$ -4.762 millions
National Research Corporation -4.84 %$ -4.838 millions
Medpace Holdings inc -5.07 %$ -5.068 millions
Catalyst Pharmaceuticals Inc -5.39 %$ -5.386 millions
Repligen Corp -5.93 %$ -5.925 millions
Becton Dickinson And Company -7.51 %$ -7.511 millions
Electromed Inc -9.43 %$ -9.434 millions
Semler Scientific Inc -12.69 %$ -12.687 millions
Cannis Inc -14.57 %$ -14.569 millions
Boston Scientific Corporation -18.98 %$ -18.976 millions
Novocure Limited -19.41 %$ -19.408 millions
Bio techne Corp -19.94 %$ -19.939 millions
Baxter International Inc -20.26 %$ -20.256 millions
Intuitive Surgical Inc -27.25 %$ -27.247 millions
Macrogenics Inc -27.98 %$ -27.977 millions
Integra Lifesciences Holdings Corp -31.75 %$ -31.751 millions
Edwards Lifesciences Corporation -32.24 %$ -32.239 millions
Collegium Pharmaceutical inc -35.72 %$ -35.722 millions
Owens and Minor Inc -36.61 %$ -36.606 millions
Bio rad Laboratories Inc -40.72 %$ -40.720 millions
Bausch Health Companies Inc -41.00 %$ -41.003 millions
Atrion Corporation -41.28 %$ -41.284 millions
Amphastar Pharmaceuticals Inc -41.83 %$ -41.827 millions
Johnson and Johnson -41.96 %$ -41.964 millions
Mylan N v -43.27 %$ -43.265 millions
Mallinckrodt Plc -43.58 %$ -43.579 millions
Novus Therapeutics Inc -45.39 %$ -45.389 millions
Jrsis Health Care Corp -50.12 %$ -50.124 millions
Abiomed Inc -50.86 %$ -50.859 millions
U s Neurosurgical Holdings Inc -52.66 %$ -52.664 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LAKF's Profile

Stock Price

LAKF's Financials

Business Description

Fundamentals

Charts & Quotes

LAKF's News

Suppliers

LAKF's Competitors

Customers & Markets

Economic Indicators

LAKF's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071